Araceli and Monica, the longest-serving resident of Los Olmos nursing home and the youngest health care provider, accompanied by staff from the nursing home, after receiving their second dose of Pfizer-BioNTech vaccine, in Guadalajara, Castilla-La Mancha (Spain), on January 18, 2021. Araceli Rosario Hidalgo, an intern at Los Olmos nursing home in Guadalajara since 2013 and born in 1924, and Monica Tapias, born in 1972, an auxiliary care nurse technician (ANC) who has been working at the center for ten years, were the first two people to receive the COVID-19 vaccine in Spain and today they have received the second dose. 18 JANUARY 2021;CORONAVIRUS VACCINATION;SECOND DOSE RAFAEL MARTÃN LagenciaEP 01 18 2021 Guadalajara (Castilla-La Manch
Choose your license
Rights Managed:
One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.
One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.
Media Info
Credit: Lagencia
Media ID:
Recording Date: Jan 18, 2021
Media Size: 4,814×2,999 Pixels
Araceli and Monica, the longest-serving resident of Los Olmos nursing home and the youngest health care provider, accompanied by staff from the nursing home, after receiving their second dose of Pfizer-BioNTech vaccine, in Guadalajara, Castilla-La Mancha (Spain), on January 18, 2021. Araceli Rosario Hidalgo, an intern at Los Olmos nursing home in Guadalajara since 2013 and born in 1924, and Monica Tapias, born in 1972, an auxiliary care nurse technician (ANC) who has been working at the center for ten years, were the first two people to receive the COVID-19 vaccine in Spain and today they have received the second dose. 18 JANUARY 2021;CORONAVIRUS VACCINATION;SECOND DOSE RAFAEL MARTÃN LagenciaEP 01 18 2021 Guadalajara (Castilla-La Manch
Release Info: Do I need a release?
Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.
Need a custom license?
If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.
